Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026
(NASDAQ: OCUL) Delayed: 10.22 +0.25 (2.51%)
Previous Close $9.97    52 Week High $14.50 
Open $9.83    52 Week Low $4.04 
Day High $10.59    P/E N/A 
Day Low $9.80    EPS $0.00 
Volume 985,844